Collective Molecular Activities of the Plant: Eucalyptus Viminalis
Plant ID: NPO28778
Plant Latin Name: Eucalyptus Viminalis
Taxonomy Genus: Eucalyptus
Taxonomy Family: Myrtaceae
Plant External Links:
NCBI TaxonomyDB:
155764
Plant-of-the-World-Online:
n.a.
Country/Region:
Australia; ChinaTraditional Medicine System:
TCMMedicinal Functions:
Antiviral; Laxative
Australia; China
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Overview of Ingredients
81 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
62 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
30 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC95676
Ingredient ID: NPC94304
Ingredient ID: NPC94218
Ingredient ID: NPC94045
Ingredient ID: NPC93033
Ingredient ID: NPC90787
Ingredient ID: NPC85813
Ingredient ID: NPC85327
Ingredient ID: NPC84319
Ingredient ID: NPC82648
Ingredient ID: NPC82363
Ingredient ID: NPC79527
Ingredient ID: NPC78540
Ingredient ID: NPC76145
Ingredient ID: NPC76074
Ingredient ID: NPC68492
Ingredient ID: NPC62086
Ingredient ID: NPC5708
Ingredient ID: NPC4827
Ingredient ID: NPC4125
Ingredient ID: NPC3922
Ingredient ID: NPC3649
Ingredient ID: NPC327254
Ingredient ID: NPC3190
Ingredient ID: NPC312391
Ingredient ID: NPC306616
Ingredient ID: NPC299529
Ingredient ID: NPC289758
Ingredient ID: NPC281994
Ingredient ID: NPC270088
Ingredient ID: NPC270074
Ingredient ID: NPC269806
Ingredient ID: NPC268862
Ingredient ID: NPC266021
Ingredient ID: NPC26583
Ingredient ID: NPC265513
Ingredient ID: NPC261831
Ingredient ID: NPC261411
Ingredient ID: NPC258723
Ingredient ID: NPC258019
Ingredient ID: NPC257522
Ingredient ID: NPC249018
Ingredient ID: NPC243601
Ingredient ID: NPC229403
Ingredient ID: NPC225406
Ingredient ID: NPC225284
Ingredient ID: NPC223417
Ingredient ID: NPC219573
Ingredient ID: NPC217781
Ingredient ID: NPC215702
Ingredient ID: NPC213322
Ingredient ID: NPC20892
Ingredient ID: NPC207869
Ingredient ID: NPC206380
Ingredient ID: NPC202691
Ingredient ID: NPC200872
Ingredient ID: NPC197378
Ingredient ID: NPC194383
Ingredient ID: NPC181582
Ingredient ID: NPC180612
Ingredient ID: NPC178859
Ingredient ID: NPC176017
Ingredient ID: NPC17458
Ingredient ID: NPC173658
Ingredient ID: NPC170070
Ingredient ID: NPC166894
Ingredient ID: NPC163424
Ingredient ID: NPC162169
Ingredient ID: NPC157923
Ingredient ID: NPC15292
Ingredient ID: NPC149691
Ingredient ID: NPC149570
Ingredient ID: NPC149203
Ingredient ID: NPC148677
Ingredient ID: NPC142871
Ingredient ID: NPC127447
Ingredient ID: NPC125962
Ingredient ID: NPC121270
Ingredient ID: NPC114239
Ingredient ID: NPC105380
Ingredient ID: NPC100178
Classification of Human Proteins Collectively Targeted by the Plant
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
| Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
| Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
| Cytochrome P450 | Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
| Therapeutic Target | Enzyme | AKR1C3 | Aldo-keto-reductase family 1 member C3 | P42330 | CHEMBL4681 |
| Therapeutic Target | Fatty acid binding protein family | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
| Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
| Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
| Therapeutic Target | Nuclear hormone receptor subfamily 1 | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
| Therapeutic Target | Oxidoreductase | CBR1 | Carbonyl reductase [NADPH] 1 | P16152 | CHEMBL5586 |
| Therapeutic Target | Oxidoreductase | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
| Therapeutic Target | Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
| Therapeutic Target | Oxidoreductase | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
| Therapeutic Target | Serine protease | F10 | Coagulation factor X | P00742 | CHEMBL244 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
| Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 84 | |
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT01557296 | Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis | gastroparesis | Glucose, Liquid (NPC289758) | NP level |
| NCT02752308 | Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair | hypospadias | Glucose, Liquid (NPC289758) | NP level |
| NCT04895358 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) | breast neoplasm | Glucose, Liquid (NPC289758) | NP level |
| NCT04726436 | Dextrose Effect on Postoperative Nausea and Vomiting (PONV) | post operative nausea and vomiting | Glucose, Liquid (NPC289758) | NP level |
| NCT00823108 | Rapid Administration of Insulin in Sepsis | septic shock | Glucose, Liquid (NPC289758) | NP level |
| NCT00062972 | Improving Memory in Patients With Multiple Sclerosis | multiple sclerosis | Glucose, Liquid (NPC289758) | NP level |
| NCT02374281 | Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking | pain | Glucose, Liquid (NPC289758) | NP level |
| NCT01661764 | Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | colorectal adenoma | Oleic Acid (NPC261831) | NP level |
| NCT03994471 | Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. | chronic kidney disease | Glucose, Liquid (NPC289758) | NP level |
| NCT00337597 | Continuous Regional Analgesia After Total Knee Arthroplasty | pain | Glucose, Liquid (NPC289758) | NP level |
| NCT05160532 | Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis | osteoarthritis | Glucose, Liquid (NPC289758) | NP level |
| NCT00632775 | 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children | Hyponatremia | Glucose, Liquid (NPC289758) | NP level |
| NCT04832009 | Reversing Glucose and Lipid-mediated Vascular Dysfunction | hypertension | Glucose, Liquid (NPC289758) | NP level |
| NCT02678208 | The Effect of Tranexamic Acid on Uterine Blood Flow After Vaginal Delivery | postpartum hemorrhage | Glucose, Liquid (NPC289758) | NP level |
| NCT01547364 | Caudal Epidural Injection of Dextrose For Low Back Pain | Low back pain | Glucose, Liquid (NPC289758) | NP level |
| NCT01753882 | Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI) | Spinal cord injury | Glucose, Liquid (NPC289758) | NP level |
| NCT05029037 | High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial. | COVID-19 | Glucose, Liquid (NPC289758) | NP level |
| NCT02728037 | Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain | pain | Glucose, Liquid (NPC289758) | NP level |
| NCT00639808 | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis | gastroparesis | Glucose, Liquid (NPC289758) | NP level |
| NCT01883440 | Glucose Oxidase as Treatment Against Common Cold | common cold | Glucose, Liquid (NPC289758) | NP level |
| NCT05326763 | Functional and Electromyographical Changes After PRP or Dextrose Injection in Chronic Lateral Epicondylitis | lateral epicondylitis | Glucose, Liquid (NPC289758) | NP level |
| NCT03690583 | Immunomodulation by Zinc Supplementation in Children With Pneumonia | pneumonia | Glucose, Liquid (NPC289758) | NP level |
| NCT03337477 | A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8 | Hyperkalemia | Glucose, Liquid (NPC289758) | NP level |
| NCT00213759 | Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF | neutropenia | Glucose, Liquid (NPC289758) | NP level |
| NCT02910518 | A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus | type 1 diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT02185729 | Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers | metabolic disease | Glucose, Liquid (NPC289758) | NP level |
| NCT05185999 | Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients | chronic kidney disease | Glucose, Liquid (NPC289758) | NP level |
| NCT04392622 | d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma | xerostomia | Limonene (NPC76145) | NP level |
| NCT00800085 | Beta Cell Function in (Pre) Type 1 Diabetes | type 1 diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT02596477 | Evaluation of Vepoloxamer in Chronic Heart Failure | heart failure | Glucose, Liquid (NPC289758) | NP level |
| NCT01210183 | Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose | osteoarthritis | Glucose, Liquid (NPC289758) | NP level |
| NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Glucose, Liquid (NPC289758) | NP level |
| NCT02591927 | Reappraisal of GIK in Acute STEMI by Pre-hospital Administration | myocardial infarction | Glucose, Liquid (NPC289758) | NP level |
| NCT01223690 | Clarithromycin as Immunomodulator for the Management of Sepsis | Sepsis;septic shock | Glucose, Liquid (NPC289758) | NP level |
| NCT03860688 | Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins | hyperlipidemia | Glucose, Liquid (NPC289758) | NP level |
| NCT02054325 | Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins | Varicose veins | Glucose, Liquid (NPC289758) | NP level |
| NCT02710266 | Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection | liver disease | Glucose, Liquid (NPC289758) | NP level |
| NCT01075984 | Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) | fungal infectious disease | Glucose, Liquid (NPC289758) | NP level |
| NCT03357666 | Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis | bacterial vaginosis | Glucose, Liquid (NPC289758) | NP level |
| NCT00686608 | Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients | obesity | Glucose, Liquid (NPC289758) | NP level |
| NCT03577730 | Caffeine and Neurologic Recovery Following Surgery and General Anesthesia | pain | Glucose, Liquid (NPC289758) | NP level |
| NCT00638196 | Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS | multiple sclerosis | Oleic Acid (NPC261831) | NP level |
| NCT04853082 | Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution | Hepatic steatosis | Limonene (NPC76145) | NP level |
| NCT03039673 | MIROCALS: Modifying Immune Response and OutComes in ALS | amyotrophic lateral sclerosis | Glucose, Liquid (NPC289758) | NP level |
| NCT04133922 | Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes | type 1 diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT02325583 | Intraoral 30% Glucose Effect In Newborns | epilepsy | Glucose, Liquid (NPC289758) | NP level |
| NCT00029679 | Borage Oil and Ginkgo Biloba (EGb 761) in Asthma | asthma | Linoleic Acid (NPC85813) | NP level |
| NCT04557878 | Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction | temporomandibular joint disorder | Glucose, Liquid (NPC289758) | NP level |
| NCT02269735 | A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001) | type 1 diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT01307904 | The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects | diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT00091507 | IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. | congestive heart failure;intermediate coronary syndrome;myocardial infarction | Glucose, Liquid (NPC289758) | NP level |
| NCT00552786 | Antioxidation Medication for Noise-induced Hearing Loss | hearing loss | Glucose, Liquid (NPC289758) | NP level |
| NCT02866435 | Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes | Hypoglycemia | Glucose, Liquid (NPC289758) | NP level |
| NCT00617981 | Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Glucose, Liquid (NPC289758) | NP level |
| NCT01548612 | Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia | schizophrenia | Glucose, Liquid (NPC289758) | NP level |
| NCT00607945 | Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Linoleic Acid (NPC85813) | NP level |
| NCT01121354 | Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX | infection | Glucose, Liquid (NPC289758) | NP level |
| NCT00951158 | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | neoplasm | Linoleic Acid (NPC85813) | NP level |
| NCT02632630 | Nutrition Supplementation in Hospitalized Patients | malnutrition | Glucose, Liquid (NPC289758) | NP level |
| NCT04088591 | High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda | Sepsis | Glucose, Liquid (NPC289758) | NP level |
| NCT04001036 | Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD | chronic kidney disease | Glucose, Liquid (NPC289758) | NP level |
| NCT05424315 | Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients | myocardial infarction | Glucose, Liquid (NPC289758) | NP level |
| NCT02319512 | Effects of Chewing Gum Against Postoperative Ileus | ileus | Glucose, Liquid (NPC289758) | NP level |
| NCT01792310 | A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours | glioma | Oleic Acid (NPC261831) | NP level |
| NCT04791202 | Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis | pain | Glucose, Liquid (NPC289758) | NP level |
| NCT01251770 | Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children | Hyponatremia | Glucose, Liquid (NPC289758) | NP level |
| NCT00617552 | Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery | ileus | Glucose, Liquid (NPC289758) | NP level |
| NCT04918719 | Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke | Ischemic stroke | Glucose, Liquid (NPC289758) | NP level |
| NCT04677829 | Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI) | brain injury | Glucose, Liquid (NPC289758) | NP level |
| NCT05205486 | Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults | infection | Glucose, Liquid (NPC289758) | NP level |
| NCT03241706 | Liver Glycogen and Hypoglycemia in Humans | Hypoglycemia | Glucose, Liquid (NPC289758) | NP level |
| NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | breast cancer | Linoleic Acid (NPC85813) | NP level |
| NCT03024814 | Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants | hemorrhage | Glucose, Liquid (NPC289758) | NP level |
| NCT01485315 | Transfusion-requirements in Septic Shock Trial | septic shock | Glucose, Liquid (NPC289758) | NP level |
| NCT03205553 | Direct Peritoneal Resuscitation in Gastroschisis | gastroschisis | Glucose, Liquid (NPC289758) | NP level |
| NCT01909336 | Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia | Hyponatremia | Glucose, Liquid (NPC289758) | NP level |
| NCT02063802 | Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | obesity | Linoleic Acid (NPC85813) | NP level |
| NCT01300260 | Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose | type 2 diabetes mellitus | Glucose, Liquid (NPC289758) | NP level |
| NCT00204932 | Effects of CLA Supplements on Body Weight and Fat Oxidation | obesity | Linoleic Acid (NPC85813) | NP level |
| NCT00835939 | Treatment for Achilles Tendinopathy | Tendinopathy | Glucose, Liquid (NPC289758) | NP level |
| NCT00612014 | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis | gastroparesis | Glucose, Liquid (NPC289758) | NP level |
| NCT04409665 | The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST) | respiratory failure | Glucose, Liquid (NPC289758) | NP level |
| NCT01788969 | Serotonergic Modulation of Motor Function in Subacute and Chronic SCI | Spinal cord injury | Glucose, Liquid (NPC289758) | NP level |
| NCT02180412 | Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria | porphyria | Glucose, Liquid (NPC289758) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
AKR1B10,CA4,FABP5,AKR1C3,FABP4,CYP19A1,AKR1B10,CYP19A1,AKR1C3
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
AKR1B10,FABP5,ALOX15,XDH,FFAR4,CA7,FFAR1,CYP19A1
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
LMNA,PPARA,FABP5,F10,FABP4,FABP3,FFAR1,CBR1
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
AKR1B10,LMNA,ALOX15,XDH,FFAR4,CA7,FFAR1,CBR1
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
CA4,F10,FABP5,FABP3,CA7,FFAR1,CYP19A1,CBR1
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
AKR1B10,CYP1A2,FABP5,ALOX15,XDH,FFAR4,FABP3
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
AKR1B10,FABP5,XDH,FFAR4,CYP19A1,FFAR4,FABP5
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
AKR1B10,CA4,FABP5,FABP4,FABP3,CYP19A1
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
NCT02728037,NCT03577730,NCT02374281,NCT00337597,NCT04791202
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
AKR1B10,AKR1C3,XDH,CA7,CBR1
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
AKR1B10,AKR1C3,XDH,CA7,CBR1
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
AKR1B10,FABP5,ALOX15,FFAR4,CYP1B1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
AKR1B10,LMNA,FABP5,CYP1B1,CYP19A1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
XDH
NCT04001036,NCT03994471,NCT05185999 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
FFAR1,PPARA
NCT01300260,NCT00607945 |
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT02910518,NCT04133922,NCT00800085,NCT02269735
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
CA4,F10,FABP5,XDH
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
F10,LMNA,CA4,FABP3
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
XDH,CYP1B1,CA7,FFAR1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
AKR1B10,ALOX15,XDH,CYP1A1
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,XDH,FFAR1,CYP19A1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
CA4,FABP5,XDH,FABP3
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CA4,XDH,PPARA
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
CBR1,CA4
NCT00029679 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CYP19A1,CA4
NCT00908791 |
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT00686608,NCT00204932,NCT02063802
|
Septic shockDisease Category: X.Extension CodesDisease ICD-11 Code: XS26 |
NCT01223690,NCT00823108,NCT01485315
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
NCT00091507,NCT05424315,NCT02591927
|
GastroparesisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA41.00 |
NCT01557296,NCT00612014,NCT00639808
|
Hypo-kalaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C77 |
NCT01251770,NCT01909336,NCT00632775
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
LMNA,CA4,FABP5
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
AKR1B10,AKR1C3,XDH
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ALOX15,CYP2C19,CYP1A1
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
NCT02596477 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
PPARA,FFAR1
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
PPARA,XDH
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
PPARA
FABP4 |
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
PPARA
NCT01307904 |
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PPARA
NCT03860688 |
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT01788969,NCT01753882
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT04088591,NCT01223690
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT01210183,NCT05160532
|
Hypoglycaemia without associated diabetesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A41 |
NCT02866435,NCT03241706
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT05205486,NCT01121354
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NCT00062972,NCT00638196
|
Postoperative ileusDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA91-DB30 |
NCT00617552,NCT02319512
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
AKR1B10,FABP5
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
ALOX15,CYP19A1
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
AKR1C3,FABP4
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
CYP19A1,CBR1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
FABP3,FFAR1
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
FABP5,ALOX15
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
FFAR1,CYP1A1
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CYP1A2,CYP1A1
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
FFAR4,CYP1B1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
AKR1B10,AKR1C3
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
AKR1B10,LMNA,F10,AKR1C3,XDH,FFAR4,CYP1B1,FABP3,CA7,ALOX15,CYP2C19,CBR1
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PPARA
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA4
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
XDH
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
F10
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PPARA
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FFAR1
|
Venous thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD72 |
F10
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
AKR1C3
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
PPARA
|
Coronary thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA43 |
F10
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Supraventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81 |
F10
|
Blood-forming organ diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
F10
|
Christmas diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B11 |
F10
|
Coagulation defectDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B10 |
F10
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA4
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
AKR1C3
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F10
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA4
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
F10
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
F10
|
DyslipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80-5C81 |
PPARA
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
F10
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT00617981
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT05029037
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT03024814
|
Varicose veinsDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD74-BD75 |
NCT02054325
|
PolyuriaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF55 |
NCT02180412
|
Hearing disorderDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB50-AB57 |
NCT00552786
|
GastroschisisDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LB02 |
NCT03205553
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT04895358
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT00213759
|
Unspecified undernutritionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B7Z |
NCT02632630
|
HypospadiasDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LB53 |
NCT02752308
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT03690583
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT01548612
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT00091507
|
Unstable anginaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40.0 |
NCT00091507
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT04409665
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT03778593
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT04832009
|
Diseases of the musculoskeletal system or connective tissue, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FC0Z |
NCT00835939
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT01883440
|
Temporomandibular joint disordersDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0E.8 |
NCT04557878
|
Vaginal dischargeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF3A |
NCT03357666
|
HyperkalaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C76 |
NCT03337477
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT04918719
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT02185729
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT01547364
|
Intracranial injury, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.Z |
NCT04677829
|
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT02325583
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00951158
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT03039673
|
Postpartum haemorrhageDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA43 |
NCT02678208
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT04726436
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB10Z |
NCT02710266
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT04853082
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
NCT01661764
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01792310
|
Skin fungal infection disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA60 |
NCT01075984
|
XerostomiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.1 |
NCT04392622
|
Lateral epicondylitis of elbowDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB55.1 |
NCT05326763
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CYP1A1
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
AKR1B10
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
Malignant neoplasms of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
FABP4
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
CA4
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CYP1A1
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
ALOX15
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CYP1A2
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
FABP4
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
FABP4
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
FFAR4
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FFAR1
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
FABP4
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
>> Targets derived from weak experimental activities
